申请人:HERGENROTHER Paul J.
公开号:US20090012088A1
公开(公告)日:2009-01-08
Compounds and related methods for synthesis, and the use of compounds for the treatment of neurodegenerative diseases are disclosed. Compounds are disclosed in connection with PARG and/or PARP inhibition. Therapeutic applications are relevant for preventing or inhibiting neurological cell death for a variety of neurodegenerative conditions including Parkinson's disease, ischemia, and stroke. Also disclosed is a high-throughput screen for identifying compounds capable of inhibiting PARG and/or PARP.
本发明披露了合成的化合物及相关方法,并使用这些化合物治疗神经退行性疾病。本发明涉及与PARG和/或PARP抑制相关的化合物。治疗应用涉及预防或抑制多种神经退行性疾病,包括帕金森病、缺血和中风引起的神经细胞死亡。还披露了一种高通量筛选方法,用于识别能够抑制PARG和/或PARP的化合物。